Personalized medicine
The multiple sclerosis-focused company will use the funds to speed up the company's commercialization efforts.
The Ohio-based company's XR90 offering allows physicians to view a patient's anatomical structures in 3D for preoperative and intraoperative use.
The funding comes three months after the company announced it added AI-enabled imaging features and new indications expanding xvision's use to the whole spine.
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
The funds will be used to expand its research and development teams in the U.S. and Israel.
Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.
Artificial intelligence can help free clinicians from administrative tasks so they can focus on one-on-one patient care, according to Dave Brown, CEO at QiiQ and Thanos Melitsiotis, CPO at QiiQ.
Dr. Oliver Bleck, area head of Europe South at Roche, describes the pharma giant's work in personalized medicine.
One of the projects will develop a digital navigator to support people with chronic conditions.
HIMSS22
Founder and CEO of b.well Connected Health Kristen Valdes believes that proper use of data can help healthcare organizations keep patient engagement high through more effective communication.